{"schema_version":"secwatch.filing_event.v1","accession":"0001819790-25-000003","form_type":"8-K","ticker":"TARS","cik":"0001819790","company_name":"Tarsus Pharmaceuticals, Inc.","filed_at":"2025-01-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.054769+00:00","generated_at":"2026-05-27T23:23:50.813486+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Tarsus board member Rosemary Crane resigns, becomes consultant; committee changes","bullets":["Rosemary Crane resigned from Board and committees effective Jan 17, 2025; not due to any disagreement.","Crane entered a 6-month consulting agreement with Tarsus, continuing to vest in equity awards.","Wendy Yarno appointed Chairperson of Commercial Committee; steps off Audit Committee effective Jan 17.","Andrew Goldberg, M.D. appointed to Audit Committee effective Jan 17, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001819790-25-000003","json":"https://secwatch.observer/filing/0001819790-25-000003.json","markdown":"https://secwatch.observer/filing/0001819790-25-000003.md","text":"https://secwatch.observer/filing/0001819790-25-000003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000003/0001819790-25-000003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000003/tars-20250115.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T23:23:50.813486+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6dd978b173","claim":"Rosemary Crane resigned as Director at Tarsus Pharmaceuticals, Inc..","evidence_excerpt":"On January 15, 2025, Rosemary Crane, a member of the Board of Directors (the “Board”) of Tarsus Pharmaceuticals, Inc. (the “Company”) notified the Company of her resignation as a member of the Board and any committees of the Board, effective January 17, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000003/0001819790-25-000003-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}